IRIS UniCatt

Hohaus, Stefan
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.162
EU - Europa 6.857
AS - Asia 5.068
SA - Sud America 1.090
AF - Africa 160
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 9
Totale 20.372
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.940
SG - Singapore 2.387
DE - Germania 2.266
CN - Cina 1.510
SE - Svezia 1.109
BR - Brasile 914
PL - Polonia 715
IT - Italia 710
UA - Ucraina 451
FR - Francia 381
GB - Regno Unito 324
IE - Irlanda 247
IN - India 246
FI - Finlandia 238
VN - Vietnam 222
ID - Indonesia 169
RU - Federazione Russa 126
CA - Canada 108
TR - Turchia 79
MX - Messico 73
HK - Hong Kong 68
BD - Bangladesh 67
AR - Argentina 54
JP - Giappone 54
IQ - Iraq 42
AT - Austria 40
ZA - Sudafrica 39
NL - Olanda 37
BE - Belgio 35
CI - Costa d'Avorio 32
ES - Italia 32
PK - Pakistan 29
EC - Ecuador 26
KR - Corea 26
CO - Colombia 25
CZ - Repubblica Ceca 25
VE - Venezuela 25
IR - Iran 24
AU - Australia 23
MA - Marocco 22
LT - Lituania 21
CH - Svizzera 18
KE - Kenya 18
AE - Emirati Arabi Uniti 17
UZ - Uzbekistan 17
PY - Paraguay 16
IL - Israele 13
GR - Grecia 12
AZ - Azerbaigian 11
MY - Malesia 11
PE - Perù 11
RO - Romania 11
TN - Tunisia 11
EG - Egitto 9
SA - Arabia Saudita 9
CL - Cile 8
CR - Costa Rica 8
JO - Giordania 8
KZ - Kazakistan 8
LV - Lettonia 8
BG - Bulgaria 7
DZ - Algeria 7
NP - Nepal 7
UY - Uruguay 7
ET - Etiopia 6
NO - Norvegia 6
AL - Albania 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
GE - Georgia 5
HN - Honduras 5
JM - Giamaica 5
PT - Portogallo 5
XK - ???statistics.table.value.countryCode.XK??? 5
BY - Bielorussia 4
CG - Congo 4
EU - Europa 4
HU - Ungheria 4
PH - Filippine 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
BO - Bolivia 3
CU - Cuba 3
HR - Croazia 3
KW - Kuwait 3
LB - Libano 3
NI - Nicaragua 3
OM - Oman 3
SN - Senegal 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BH - Bahrain 2
CY - Cipro 2
GT - Guatemala 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
LY - Libia 2
MN - Mongolia 2
NG - Nigeria 2
Totale 20.339
Salva come PNG Salva come JPEG
Città #
Singapore 1.158
Chandler 1.039
Warsaw 688
Ashburn 672
Jacksonville 336
Beijing 273
Munich 257
Dublin 239
San Mateo 223
Nanjing 222
Los Angeles 211
Houston 204
Ann Arbor 201
Fairfield 200
Woodbridge 195
Dearborn 193
New York 184
Wilmington 184
Jakarta 154
Rome 144
Milan 136
Hefei 134
Nürnberg 122
Seattle 112
Helsinki 110
Dallas 101
Chicago 100
Cattolica 98
Boston 88
Bremen 88
Frankfurt am Main 86
Nanchang 85
Moscow 84
Redmond 77
The Dalles 77
Lawrence 72
São Paulo 71
Redwood City 68
Buffalo 64
Hong Kong 63
Ho Chi Minh City 61
Hanoi 59
Princeton 58
Hyderabad 56
Marseille 56
Kunming 54
London 50
Cambridge 47
Lancaster 46
Santa Clara 44
Izmir 40
Shanghai 40
Kent 38
Norwalk 35
Hangzhou 33
Abidjan 32
Nuremberg 32
Tianjin 32
Brussels 31
Guangzhou 31
Hebei 31
Montreal 31
Tokyo 31
Brooklyn 30
Toronto 30
Mountain View 29
Shenyang 29
Zhengzhou 29
Boardman 28
Jiaxing 27
Rio de Janeiro 27
Orem 26
Seoul 26
Changsha 25
Auburn Hills 24
Belo Horizonte 24
Fremont 24
Leawood 23
Mexico City 23
Johannesburg 22
Atlanta 21
Stockholm 21
Turku 21
University Park 21
Phoenix 20
Poplar 20
Denver 19
Düsseldorf 19
Nairobi 18
Vienna 17
Ankara 16
Augusta 16
Baghdad 16
Brasília 16
Haiphong 16
Jinan 16
Pune 16
Brno 15
Portsmouth 15
Tampa 15
Totale 10.581
Salva come PNG Salva come JPEG
Nome #
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 402
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 340
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 321
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 315
Fanconi anemia gene variants in therapy-related myeloid neoplasms 302
THE PROGNOSTIC ROLE OF EBV IN PERIPHERAL BLOOD OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA 272
Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients 271
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 262
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 260
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 216
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 216
Italian real-life experience with brentuximab vedotin: Results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma 213
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 202
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 199
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin 198
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 191
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 173
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 173
Why methylation is not a marker predictive of response to hypomethylating agents 173
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 170
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 170
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 169
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 169
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 167
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 167
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 165
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 163
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 163
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 163
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 161
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 159
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 159
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 157
Epigenetic changes in therapy-related MDS/AML 156
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 155
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 151
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 149
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 148
Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma 148
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 146
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 146
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma 143
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 143
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 142
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 142
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas 141
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. 141
Iron in Hodgkin's lymphoma 139
Primary multifocal lymphoma of peripheral nervous system: Case report and review of the literature 139
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication. 139
Intravascular large-B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negative. 136
Efficacy of a modified Stanford V regimen in patients with advanced Hodgkin's lymphoma. 136
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma 136
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) 136
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma. 136
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 136
Interim FDG-PET/CT in Hodgkin lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET). 135
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine 134
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine. 134
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 134
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma. 132
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 131
The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes 131
Intravascular large B-cell lymphoma presenting as slowly progressive paraparesis with normal MRI features 130
PU.1 and CEBPA expression in acute myeloid leukemia. 130
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 130
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 128
FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET) 128
Small lymphocytic lymphoma in a patient with Fabry disease 126
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 126
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 126
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias 125
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. 125
Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas 124
Mantle cell lymphoma relapsing at the lymphedematous arm 123
Desensitization to thalidomide in a patient with multiple myeloma 121
Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. 121
Clinical and prognostic features of lymphomas arising in the head and neck region: Our experience of preferential association of different histotypes with various sites of origin in ninety patients 121
Prognostic factors in hodgkin lymphoma 121
Outcome of therapy-related myeloid neoplasms treated with azacitidine 120
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 120
Cardiovascular involvement in patients affected by multiple myeloma: a comprehensive review of recent advances 120
Primary pancreatic lymphoma in a patient with maturity onset diabetes of the young type 3 119
Clonal evolution in therapy-related neoplasms 116
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry 115
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 115
Small lymphocytic lymphoma in a patient with Fabry disease 114
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 114
Muscle Recurrence of a Primarily Nodal Follicular Lymphoma Studied by Contrast-Enhanced 18F-FDG PET/CT 114
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 113
Chemoradiotherapy with temozolomide after high-dose methotrexate for primary CNS lymphoma: a multicenter phase I study of a response-adapted strategy 113
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma 112
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 112
Prognostic role of gender in diffuse large B-cell lymphoma treated with rituximab containing regimens: a Fondazione Italiana Linfomi/Grupo de Estudos em Moléstias Onco-Hematológicas retrospective study. 111
Dural MALT Lymphoma Detected by 11C-Methionine PET/CT 111
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma 110
Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule 109
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 109
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 109
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 108
Totale 15.605
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.614
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.614
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021924 0 0 0 0 0 146 178 36 144 82 287 51
2021/20221.293 151 111 20 53 85 36 38 206 64 102 208 219
2022/20232.865 385 396 203 502 180 353 140 230 303 49 84 40
2023/20241.300 56 383 42 66 39 204 52 87 11 39 150 171
2024/20253.391 98 114 247 159 298 119 229 167 456 289 675 540
2025/20264.815 1.167 281 517 857 1.600 393 0 0 0 0 0 0
Totale 20.613